BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Mark Massaro does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ADPTAdaptive Biotechnologies Corp | Buy | $9.00 | Dec 2024 | +160.0% | Hit |
| ADPTAdaptive Biotechnologies Corp | Buy | $8.00 | Oct 2024 | +185.2% | Hit |
 DNAGinkgo Bioworks Holdings | Sell | $7.00 | Aug 2024 | −63.8% | Hit |
| DNAGinkgo Bioworks Holdings | Sell | $0.20 | Jun 2024 | +15.8% | Hit |
 BNGOBionano Genomics Inc | Buy | $2.00 | May 2024 | −86.9% | Miss |
| DNAGinkgo Bioworks Holdings | Sell | — | May 2024 | +67.9% | — |
| ADPTAdaptive Biotechnologies Corp | Buy | $5.00 | Apr 2024 | +193.6% | Hit |
 SOPHSophia Genetics SA | Buy | $8.00 | Mar 2024 | −41.0% | Miss |
| BNGOBionano Genomics Inc | Buy | $10.00 | Aug 2023 | −102.6% | Miss |
| BNGOBionano Genomics Inc | Buy | $2.00 | May 2023 | −96.2% | Miss |
 MDXHMDxHealth SA ADR | Buy | $7.00 | May 2023 | −42.0% | Miss |
 XGNExagen Inc | Buy | $5.00 | Mar 2023 | −43.7% | Miss |
| SOPHSophia Genetics SA | Buy | $6.00 | Jan 2023 | +116.7% | Miss |
| BNGOBionano Genomics Inc | Buy | $3.50 | Dec 2022 | −89.9% | Miss |
| XGNExagen Inc | Buy | $7.00 | Nov 2022 | −43.4% | Miss |
| MDXHMDxHealth SA ADR | Buy | $15.00 | Aug 2022 | −70.2% | Miss |
| DNAGinkgo Bioworks Holdings | Buy | $6.00 | Aug 2022 | −52.7% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.